MAPT and early-onset autosomal dominant Alzheimer disease: The aggregated tau found in the brains of Alzheimer's disease patients is known to have a β-sheet structure, and tau aggregation can be monitored in vitro by measuring changes in the fluorescence intensity of thioflavin T binding to the β-sheet structure [12].